Labcorp (LH) director reports grant of 136 Restricted Stock Units vesting Dec. 2026

Rhea-AI Filing Summary

Labcorp Holdings Inc. director Victor Bulto Carulla reported a new equity award in the form of restricted stock units. On December 1, 2025, he received 136 Restricted Stock Units, each representing the right to receive one share of Labcorp Holdings Inc. common stock. The award was reported as directly owned.

The Restricted Stock Units are scheduled to vest fully on December 1, 2026, meaning the shares underlying the award become deliverable on that date, subject to the award’s usual conditions. This filing is a routine disclosure of director equity compensation and does not involve any open‑market purchase or sale of shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bulto Carulla Victor

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	12/01/2025		A		136		(2)	(2)	Common Stock	136	$0	136	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. The Restricted Stock Units vest fully on December 1, 2026.

	/s/ Sandra D. van der Vaart, Attorney-in-Fact for Victor Bulto Carulla	12/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Labcorp (LH) disclose for Victor Bulto Carulla?

Labcorp disclosed that director Victor Bulto Carulla received an award of 136 Restricted Stock Units on December 1, 2025, reported as directly owned.

What does each Restricted Stock Unit represent in Labcorp (LH)'s Form 4 filing?

Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. common stock, as described in the filing.

When do the Restricted Stock Units granted to the Labcorp (LH) director vest?

The 136 Restricted Stock Units granted to the director are scheduled to vest fully on December 1, 2026, according to the disclosure.

Is the Labcorp (LH) director a 10% owner according to this Form 4?

The filing shows the reporting person as a Director of Labcorp Holdings Inc., and does not check the box indicating status as a 10% Owner.

How is ownership of the Labcorp (LH) Restricted Stock Units reported in the filing?

The filing reports 136 Restricted Stock Units as directly owned by the reporting person following the reported transaction.

Does this Labcorp (LH) Form 4 reflect a purchase or sale on the open market?

No. The transaction is reported as a grant of Restricted Stock Units, which are equity awards, rather than an open‑market purchase or sale of common stock.